Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

ARTLW

Artelo Biosciences (ARTLW)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARTLW
DataOraFonteTitoloSimboloCompagnia
13/05/202415:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLWArtelo Biosciences Inc
04/03/202422:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARTLWArtelo Biosciences Inc
02/03/202400:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARTLWArtelo Biosciences Inc
19/05/202023:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARTLWArtelo Biosciences Inc
18/05/202023:10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ARTLWArtelo Biosciences Inc
08/05/202022:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARTLWArtelo Biosciences Inc
15/04/202012:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARTLWArtelo Biosciences Inc
15/04/202012:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARTLWArtelo Biosciences Inc
13/04/202022:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARTLWArtelo Biosciences Inc
13/04/202012:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARTLWArtelo Biosciences Inc
07/04/202012:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARTLWArtelo Biosciences Inc
14/02/202022:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARTLWArtelo Biosciences Inc
18/11/201914:30GlobeNewswire Inc.Artelo Biosciences Announces Publication of Positive Non-Clinical Fatty Acid Binding Protein 5 Inhibitor Data in Peer-Reviewe...NASDAQ:ARTLWArtelo Biosciences Inc
14/11/201915:00GlobeNewswire Inc.Artelo Biosciences to Present at the Annual Investival Showcase in LondonNASDAQ:ARTLWArtelo Biosciences Inc
29/10/201913:30GlobeNewswire Inc.Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as Clinical Research Organization for Phase 1b/2a Study of ART2...NASDAQ:ARTLWArtelo Biosciences Inc
22/10/201915:00GlobeNewswire Inc.Artelo Biosciences to Present at the Dawson James Securities 5th Annual Small Cap Growth ConferenceNASDAQ:ARTLWArtelo Biosciences Inc
18/09/201914:00GlobeNewswire Inc.Artelo Biosciences Cannabidiol (CBD) Studies Referenced in September Issue of Nature MedicineNASDAQ:ARTLWArtelo Biosciences Inc
15/07/201922:01GlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:ARTLWArtelo Biosciences Inc
25/06/201919:00GlobeNewswire Inc.Artelo Biosciences Announces Closing of $8.0 Million Public Offering and Partial Exercise and Closing of Over-Allotment Optio...NASDAQ:ARTLWArtelo Biosciences Inc
21/06/201919:50GlobeNewswire Inc.Artelo Biosciences Announces Pricing of $8.0 Million Public Offering and Uplisting to NasdaqNASDAQ:ARTLWArtelo Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARTLW
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network